KR20010052325A - 에포틸론 유도체, 이의 제조 방법 및 이의 용도 - Google Patents

에포틸론 유도체, 이의 제조 방법 및 이의 용도 Download PDF

Info

Publication number
KR20010052325A
KR20010052325A KR1020007012437A KR20007012437A KR20010052325A KR 20010052325 A KR20010052325 A KR 20010052325A KR 1020007012437 A KR1020007012437 A KR 1020007012437A KR 20007012437 A KR20007012437 A KR 20007012437A KR 20010052325 A KR20010052325 A KR 20010052325A
Authority
KR
South Korea
Prior art keywords
formula
group
compound
alkyl
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020007012437A
Other languages
English (en)
Korean (ko)
Inventor
훼플레게르하르트
라이볼트토마스
Original Assignee
게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) filed Critical 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프)
Publication of KR20010052325A publication Critical patent/KR20010052325A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020007012437A 1998-05-08 1999-05-07 에포틸론 유도체, 이의 제조 방법 및 이의 용도 Ceased KR20010052325A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19820599.6 1998-05-08
DE19820599A DE19820599A1 (de) 1998-05-08 1998-05-08 Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP1999/003159 WO1999058534A2 (de) 1998-05-08 1999-05-07 Epithilonderivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
KR20010052325A true KR20010052325A (ko) 2001-06-25

Family

ID=7867085

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007012437A Ceased KR20010052325A (ko) 1998-05-08 1999-05-07 에포틸론 유도체, 이의 제조 방법 및 이의 용도

Country Status (14)

Country Link
US (2) US6982280B1 (https=)
EP (1) EP1077980B1 (https=)
JP (1) JP2002514649A (https=)
KR (1) KR20010052325A (https=)
AR (1) AR018344A1 (https=)
AT (1) ATE234842T1 (https=)
AU (1) AU754212B2 (https=)
CA (1) CA2330812A1 (https=)
DE (2) DE19820599A1 (https=)
ES (1) ES2195577T3 (https=)
HU (1) HUP0102283A3 (https=)
IL (1) IL139480A0 (https=)
TW (1) TW568910B (https=)
WO (1) WO1999058534A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
GB9810659D0 (en) 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
US6518421B1 (en) 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
DE10355223A1 (de) * 2003-11-26 2005-06-30 Institut für Pflanzenbiochemie (IPB) Neue Makrocyclen zur Behandlung von Krebserkrankungen
EP1674098A1 (en) 2004-12-23 2006-06-28 Schering Aktiengesellschaft Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US20110104664A1 (en) 2006-03-31 2011-05-05 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
EP2065054A1 (en) 2007-11-29 2009-06-03 Bayer Schering Pharma Aktiengesellschaft Combinations comprising a prostaglandin and uses thereof
DE102007059752A1 (de) 2007-12-10 2009-06-18 Bayer Schering Pharma Aktiengesellschaft Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
EP2070521A1 (en) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Surface-modified nanoparticles
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
EP2210584A1 (en) 2009-01-27 2010-07-28 Bayer Schering Pharma Aktiengesellschaft Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
US9764038B2 (en) 2011-12-23 2017-09-19 Innate Pharma Enzymatic conjugation of antibodies
WO2014009426A2 (en) 2012-07-13 2014-01-16 Innate Pharma Screening of conjugated antibodies
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
EP2968582B1 (en) 2013-03-15 2020-07-01 Innate Pharma Solid phase tgase-mediated conjugation of antibodies
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
JP6744212B2 (ja) 2013-06-21 2020-08-19 イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． ポリペプチドの酵素的結合
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
US5351146A (en) * 1993-03-01 1994-09-27 At&T Bell Laboratories All-optical network architecture
US5781537A (en) * 1995-07-07 1998-07-14 International Business Machines Corporation Setting up, taking down and maintaining connections in a communications network
DK1186606T4 (da) 1995-11-17 2011-12-05 Biotechnolog Forschung Gmbh Epothilonderivater, deres fremstilling og anvendelse
DE19542986A1 (de) 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung
DK1367057T3 (da) 1996-11-18 2009-01-19 Biotechnolog Forschung Gmbh Epothiloner E og F
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6304349B1 (en) * 1998-06-30 2001-10-16 Lucent Technologies Inc. WDM optical communications networks and methods for provisioning
US6445844B1 (en) * 1999-09-15 2002-09-03 Xros, Inc. Flexible, modular, compact fiber optic switch
US7092633B2 (en) * 2000-11-14 2006-08-15 University Of Texas System Board Of Regents System and method for configuring optical circuits
US6982951B2 (en) * 2000-12-21 2006-01-03 At&T Corp. Method for selecting a restoration path in a mesh network
US7212495B2 (en) * 2001-02-21 2007-05-01 Polytechnic University Signaling for reserving a communications path
AU2002305113A1 (en) * 2001-03-29 2002-10-15 Atoga Systems, Inc. Open ring architectures for optical wdm networks
US20020194339A1 (en) * 2001-05-16 2002-12-19 Lin Philip J. Method and apparatus for allocating working and protection bandwidth in a telecommunications mesh network
AU2002351589A1 (en) * 2001-06-27 2003-03-03 Brilliant Optical Networks Distributed information management schemes for dynamic allocation and de-allocation of bandwidth

Also Published As

Publication number Publication date
EP1077980B1 (de) 2003-03-19
EP1077980A2 (de) 2001-02-28
US20040259922A1 (en) 2004-12-23
CA2330812A1 (en) 1999-11-18
AU754212B2 (en) 2002-11-07
ATE234842T1 (de) 2003-04-15
US6982280B1 (en) 2006-01-03
IL139480A0 (en) 2001-11-25
WO1999058534A3 (de) 2000-01-13
DE59904632D1 (de) 2003-04-24
HUP0102283A2 (hu) 2001-10-28
TW568910B (en) 2004-01-01
AR018344A1 (es) 2001-11-14
DE19820599A1 (de) 1999-11-11
WO1999058534A2 (de) 1999-11-18
JP2002514649A (ja) 2002-05-21
ES2195577T3 (es) 2003-12-01
HUP0102283A3 (en) 2002-03-28
AU4361199A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
KR20010052325A (ko) 에포틸론 유도체, 이의 제조 방법 및 이의 용도
JP2641443B2 (ja) ５Ｈ−１，３，４−チアジアゾロ〔３，２−ａ〕ピリミジン−５−オン誘導体及びこれを有効成分とする農園芸用殺菌剤
MXPA06000951A (es) Sintesis regioselectiva de cci-779.
KR102621941B1 (ko) 라파마이신 유도체의 합성 방법
CN110272450B (zh) 一种β-硫羰基双膦酰类衍生物及其制备方法
JPH0314529A (ja) Ｆｋ‐５０６　ｃ↓１↓０‐ｃ↓１↓８中間体の合成方法
Cremonesi et al. Stereoselective synthesis of δ-heteroaryl substituted β-hydroxy-γ, δ-unsaturated α-amino acids
CA1125781A (en) Process for preparing cyclo-1,3,2-oxazaphosphoryl derivatives
CA2508341A1 (en) Processes for preparing quinolonecarboxylate derivatives
IE72173B1 (en) Astaxanthin intermediates
CA2497119A1 (en) A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
CA2031240A1 (fr) Derives dihydropyranniques, leur procedes de preparation et leur utilisation
CN120987957A (zh) 一种具有抗菌活性的3-甲基苯并呋喃[2,3-c]吡啶衍生物及合成方法和应用
KR20080047315A (ko) 3환성 케톤의 제조 방법
CN106977447A (zh) 一种结构对称的含羟基的咔唑化合物的制备方法
JP4701185B2 (ja) カンプトテシン誘導体の製造方法
Krawczyk A simple thiophosphate-based method for α-alkylidenation of lactones
EP0062068A1 (en) N-phthalidyl-5-fluorouracil derivatives
KR100645373B1 (ko) 세 고리형 테트라하이드로퓨란 락톤 화합물과 이의 제조방법
Arava et al. An efficient synthesis of 3-chloromethyl-1, 2-benzisoxazoles via modified Boekelheide rearrangement
MXPA00010953A (en) Epothilone derivatives, a method for the production thereof, and their use
CN120965749A (zh) 一种三(五氟苯基)硼烷促进的硒代磷酸酯的制备方法和医药用途
KR100247561B1 (ko) 신규한 피리디닐메틸아민 유도체와 그 제조방법 및 이를 함유하는 약제조성물
CN114181182A (zh) 一种多取代的4h-吡喃类化合物的合成方法
JPS63198673A (ja) フルフリルアルコ−ル誘導体の製造法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20001107

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040507

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051128

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060925

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20051128

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I